Scenario — STEMI with claimed aspirin allergy and concurrent COPD
advanced Cardiac · Adult · 35yr · female
Patient Information
| Dispatch | You are called to a patient (Sarah Kowalski, 35YO female) at the First Aid Post during the Fremantle Folk Festival. Bystanders report she walked in clutching her chest saying she feels 'really unwell'. |
| Patient | Sarah Kowalski — 35yr (65kg) |
| Incident History | Pt was walking between stages when she developed sudden onset crushing central chest pain radiating to her left arm approximately 20 minutes ago. Pt has a history of COPD and is normally on home oxygen. Pt denies trauma. |
| Emergency Contact | Daniel Kowalski (Husband) — 0412 774 391 |
Initial Rapid Assessment
| Response | Alert |
| Airway | Patent. No airway obstruction. No stridor. Speaking in short sentences. |
| Breathing | Laboured. Increased work of breathing. Accessory muscle use present. Audible mild wheeze bilaterally. RR elevated. DETECT & CORRECT — SpO2 89% on room air. |
| Circulation | Radial pulse rapid and weak. Skin pale, diaphoretic, cool peripherally. No external haemorrhage. |
| Disability | GCS 15 (E4V5M6). Orientated to time, place and person. Anxious and distressed. |
| Exposure | No rashes, no trauma. Central chest — patient guarding with hand over sternum. No peripheral oedema noted on brief inspection. |
Vitals
| Time | SpO2 | Resp Dist | RR | Pulse | BP | CRT | GCS | PERL | Temp | BGL | Pain |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Initial | 89% (RA) | Moderate | 24 | 108 | 98/64 | 3s | 15 | 4 4 ++ | 37.1 | 5.8 mmol/L | 8 |
| 10 mins | 92% (O2 NRB 10L/min — then titrate down to NC for COPD target 88–92%) | Mild | 20 | 98 | 102/68 | 2s | 15 | 4 4 ++ | 37.1 | 5.8 mmol/L | 5 |
History Taking
| Signs/Symptoms | Severe crushing central chest pain, shortness of breath, diaphoresis, nausea, left arm pain, dizziness. |
| Allergies | Patient states she is 'allergic to aspirin — I got a rash when I was a kid.' No documented anaphylaxis. No other known allergies. |
| Medications | Salbutamol MDI (PRN), Tiotropium inhaler (daily). Normally uses home oxygen 2L/min via nasal cannula for COPD. No phosphodiesterase-5 inhibitors. No anticoagulants. |
| Pertinent History | Known COPD — diagnosed 4 years ago. Ex-smoker (10 pack year history). No previous cardiac history. No previous aspirin reactions as an adult. Childhood aspirin rash — no anaphylaxis documented. |
| Last Oral Intake | Ate a meat pie and water approximately 1.5 hours ago. |
| Events Leading | Patient was attending the Fremantle Folk Festival with her husband. Was walking between two performance stages when she developed sudden onset chest pain. Denied any heavy exertion, fall, or impact. |
| Treatment Prior | Nil. Husband guided her to the FAP immediately. |
| Onset | Sudden onset approximately 20 minutes ago while walking between stages. No exertional trigger identified — was walking at a normal pace. |
| Pain | Central chest, crushing, heavy sensation — 'like someone is sitting on my chest'. |
| Quality | Crushing, pressure-like, constant. |
| Radiates | Radiates to left arm and jaw. |
| Severity | 8/10 at rest. |
Scenario Progression and Treatment Objectives
Diagnosis
This patient is suffering from a suspected ST-Elevation Myocardial Infarction (STEMI) with a concurrent COPD exacerbation contributing to hypoxia, compounded by patient reluctance to accept aspirin due to a reported childhood allergy.
Facilitator Triggers — if trainees miss a critical step
- ! (If the trainee does not ask about the nature of the aspirin 'allergy' — patient becomes more distressed and insists she 'cannot' take aspirin. Prompt: husband adds 'she's never actually had a serious reaction — it was a rash on her arm when she was about six'.) Facilitator note: the CPG states aspirin is administered even if the patient reports a prior reaction, unless hypersensitivity to aspirin/salicylates/NSAIDs is confirmed. A childhood rash does not constitute confirmed anaphylaxis or hypersensitivity. Trainee must recognise this distinction and administer aspirin.
- ! (If the trainee administers high-flow oxygen via NRB mask and does not titrate down toward 88–92% SpO2 target for COPD — patient's husband states 'she always uses low-flow oxygen at home, her doctor said too much is bad for her'. Facilitator note: COPD patients require controlled oxygen. Target SpO2 88–92%. Uncontrolled high-flow oxygen risks CO2 retention. Trainee must titrate oxygen appropriately.)
- ! (If GTN is administered without first confirming blood pressure ≥90 mmHg systolic — patient's BP is 98 systolic, which is borderline. Trainee must confirm BP before each GTN dose and recognise that BP is within the threshold. Facilitator note: GTN is indicated here — systolic >90 mmHg. However, the trainee must verbally confirm BP is adequate before each dose.)
- ! (If aspirin is not administered within the first 5 minutes of clinical contact — patient's pain score escalates to 9/10 and she becomes more diaphoretic. Facilitator note: aspirin administration should not be delayed in suspected ACS. Prompt trainees to address the allergy concern and administer.)
- ! (If the trainee does not request ambulance upgrade/Priority 1 transport — patient's GCS drops to 14 at 8 minutes, becoming confused. Facilitator note: this is a time-critical cardiac presentation. Early pre-notification of receiving facility and Priority 1 transport are essential.)
- ! (If pain score remains >3/10 after first GTN spray and Methoxyflurane is not offered — patient states 'the spray didn't do much, I'm still in a lot of pain'. Facilitator note: per the CPG, if pain >3/10 after 1 spray of GTN, Methoxyflurane should be administered as per ACS protocol.)
Treatment Objectives
- 1. Ensure scene safety and don appropriate PPE. Attention to hand hygiene will be given throughout the scenario.
- 2. Perform Primary Survey — establish patent airway, assess breathing and circulation, confirm GCS 15.
- 3. Position patient seated or semi-recumbent — limit exertion, do not allow patient to walk.
- 4. Apply SpO2 monitoring immediately — initial reading 89% on room air.
- 5. Administer oxygen — initiate via nasal cannula at 1–2 L/min targeting SpO2 88–92% given known COPD. If unable to achieve target via nasal cannula, upgrade to simple face mask 5–8 L/min. Do NOT administer high-flow uncontrolled oxygen to a COPD patient.
- 6. Complete Vital Sign Survey — HR 108, BP 98/64, RR 24, SpO2 89% RA, GCS 15, BGL 5.8 mmol/L, Temp 37.1°C, CRT 3s, Pain 8/10.
- 7. Conduct SAMPLE / IMISTAMBO history — specifically explore the nature of the aspirin 'allergy' (childhood rash, no anaphylaxis — not a confirmed hypersensitivity reaction).
- 8. Administer Aspirin 300 mg orally (chewed or dissolved in a small amount of water) — the CPG states aspirin is administered even if the patient reports prior aspirin use or is on anticoagulants; a childhood rash without confirmed anaphylaxis/hypersensitivity does not constitute a contraindication. Explain clearly to the patient why it is important.
- 9. Confirm GTN is not contraindicated: systolic BP 98 mmHg (≥90 mmHg — threshold met), HR 108 bpm (50–150 bpm — threshold met), no PDE5 inhibitor use in previous 24–72 hours.
- 10. Administer GTN 400 microg (1 spray) sublingually — patient must be seated or semi-recumbent. Do not shake GTN bottle prior to use.
- 11. Reassess pain score 5 minutes post GTN — if pain >3/10 and BP maintained ≥90 mmHg, administer second GTN 400 microg (1 spray) sublingually.
- 12. If pain remains >3/10 after first GTN spray: prepare and administer Methoxyflurane (Penthrox) 3 mL via Penthrox inhaler — patient self-administers intermittently to maintain analgesia. Reassess pain score.
- 13. Reassess BP before every GTN dose — confirm systolic ≥90 mmHg prior to each administration.
- 14. Consider Ondansetron 4 mg oral wafer if patient reports nausea or vomiting — confirm no contraindications (no apomorphine use).
- 15. Continuously reassure patient — maintain calm demeanour, keep patient still and supported.
- 16. Record full observations every 5 minutes given time-critical presentation.
- 17. Arrange Priority 1 ambulance transport with pre-notification of receiving facility (suspected STEMI). Provide IMISTAMBO handover to transporting crew including: aspirin administered, GTN dose/s administered, Methoxyflurane initiated if given, COPD with controlled oxygen in use, aspirin allergy discussion documented.
- 18. Scenario ends on arrival of ambulance and IMISTAMBO handover.
Clinical references: Chest Pain / Acute Coronary Syndrome · Oxygen · Aspirin · Glyceryl Trinitrate (GTN) · Methoxyflurane · Ondansetron · Chronic Obstructive Pulmonary Disease (COPD) — Acute Exacerbation · Primary Survey · Pain Assessment
How did you go? Next scenario →
Report a clinical error
Describe what you believe is incorrect. This will be flagged for clinical review.